Stand Up To Cancer - standup2cancer.orgThis is where the end of cancer begins
   Please leave this field empty

SU2C Blog Archive October 2016

Share this:
Email

Like this page on Facebook


The Moment This Cancer Survivor Never Wants To Forget

Posted on October 21, 2016, 10:15 AM
The Moment This Cancer Survivor Never Wants To ForgetCancer survivor Rodney Bostick shares his #HowIFight story and the one moment he hopes to never forget.

Immunotherapy in early stage lung cancer shows promise in a clinical trial supported in part by SU2C

Posted on October 10, 2016, 4:00 PM
Immunotherapy in early stage lung cancer shows promise in a clinical trial supported in part by SU2CCheckpoint inhibition is a form of immunotherapy that releases the anti-cancer function of patients’ own immune cells. It’s transformed the treatment of a number of cancers. Patrick Forde, MBBCh, assistant professor of oncology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, reported promising data from a study of nivolumab (Opdivo), a checkpoint inhibitor, in early-stage lung cancer at the 2016 Congress of the European Society for Medical Oncology (ESMO) in Copenhagen, Denmark, on Oct. 7.

Return to Blog